
Anondita Medicare IPO Listing at 90% Premium at ₹275.50 Per Share
Posted by : sachet | Mon Sep 01 2025

Anondita Medicare IPO Listing: The Anondita Medicare IPO was subscribed 300.89 times as of its closing. In this subscription, qualified institutional buyers (QIBs) received 153 times the allocation, and non-institutional investors (NIIs) received 531.82 times the allocation. The retail quota of the issue was subscribed to 33.09%. Before delving deeper into the topic, go through the details of the Anondita Medicare IPO.
Anondita Medicare IPO Listing
On the NSE and SME platforms, shares are listed at ₹275.50, reflecting a premium of 90% against the issue price of ₹145 per share.
Anondita Medicare IPO Details
It is a bookbuilding IPO of ₹69.50 crores, comprising a fresh issue of 0.48 crore shares. The issue will be listed on NSE and SME on its tentative listing date, 1st September 2025. The Anondita Medicare IPO date is fixed between 22nd August 2025 and 26th August 2025. The face value of Anondita Medicare IPO shares stands at ₹10 per share, and the IPO price band is set between ₹137 and ₹145 per share.
IPO Open Date | 22nd August 2025 |
IPO Close Date | 26th August 2025 |
IPO Allotment Date | 28th August 2025 |
Refund Initiation | 29th August 2025 |
Issue Size | 47,93,000 shares(aggregating up to ₹69.50 Cr) |
Fresh Issue | ₹10 per share |
Offer for sale | 1,000 Shares |
Face Value | ₹137 to ₹145 per share |
Lot Size | Bookbuilding IPO |
Issue Price Band | NSE & SME |
Issue Type | 1st September 2025 |
Listing At | 22nd August 2025 |
Listing Date | 26th August 2025 |
About Anondita Medicare Limited
Anondita Medicare Limited was incorporated in March 2024. It is engaged in the manufacturing of male condoms under its brand as COBRA. They have gained experience in the industry and supplied their products to pharma companies. Anondita Medicare Limited has partnered with global health organisations and NGOs, and is also backed by government support.
Anondita Medicare Limited Financials
The company’s financial analysis is essential before applying for the Anondita Medicare IPO. Look at the table to learn about Anondita Medicare Limited’s financials.
Year Ended | 31st March 2025 (in cr.) | 31st March 2024 (in cr.) | 31st March 2023 (in cr.) |
Assets | 78.27 | 42.92 | 37.80 |
Revenue | 77.13 | 46.56 | 36.14 |
Profit After Tax | 16.42 | 3.84 | 0.35 |
EBITDA | 25.65 | 9.09 | 3.58 |
Net Worth | 37.87 | 10.59 | 8.69 |
Reserve and surplus | 24.58 | 10.39 | 6.55 |
Total Borrowing | 27.39 | 24.01 | 22.66 |
Explanation
Anondita Medicare Limited’s revenue increased by 66% from ₹46.56 crores in March 2024 to ₹77.13 crores in March 2025. Moreover, the company’s PAT rose by 327% from ₹3.84 crores to ₹16.42 crores.
Recent Articles
Amanta Healthcare IPO GMP & Review: Apply or Avoid?
Rachit Prints IPO GMP & Review: Apply or Avoid?
Anlon Healthcare IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Vikran Engineering IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Current Infraprojects IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Sneha Organics IPO GMP: Day 1 IPO Live Updates
Abril Paper Tech IPO GMP: Day 1 IPO Live Updates
Anlon Healthcare Subscription Day 3